Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
CART-T cell therapy in young patients with relapsed/refractory ALL
Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany
CART-T cell therapy in young patients with relapsed/refractory ALL ( Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany )
23 Jan 2020
HSCT: Donor selection for patients with ALL
Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology, Gliwic...
HSCT: Donor selection for patients with ALL ( Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
23 Jan 2020
Therapy of Ph-positive adult ALL
Prof Oliver Ottmann - Cardiff University, Cardiff, UK
Therapy of Ph-positive adult ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )
23 Jan 2020
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in...
Prof Adrian Ochsenbein - University and University Hospital of Bern, Bern, Switz...
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans ( Prof Adrian Ochsenbein - University and University Hospital of Bern, Bern, Switzerland )
19 Dec 2019
Clinical outcomes of patients with FLT3-ITD-mutated R/R AML undergoing HSCT afte...
Dr Siddhartha Ganguly - The University of Kansas Health System, Kansas City, USA
Clinical outcomes of patients with FLT3-ITD-mutated R/R AML undergoing HSCT after quizartinib or salvage chemo ( Dr Siddhartha Ganguly - The University of Kansas Health System, Kansas City, USA )
19 Dec 2019
Outcomes in patients with therapy-Related AML who achieved remission with CPX-35...
Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center & Research Institute, Tampa, US...
Outcomes in patients with therapy-Related AML who achieved remission with CPX-351 versus 7 plus 3: Phase 3 exploratory analysis ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
19 Dec 2019
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise
Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise ( Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA )
8 Dec 2019
Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma
Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China
Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )
7 Dec 2019
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissio...
Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )
7 Dec 2019
Immunotherapy and targeted agents for elderly lung cancer patients
Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium
Immunotherapy and targeted agents for elderly lung cancer patients ( Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium )
28 Nov 2019
The use of radiation therapy in older adults
Dr Noam VanderWalde - University of Tennessee West Cancer Center., Memphis, USA
The use of radiation therapy in older adults ( Dr Noam VanderWalde -  University of Tennessee West Cancer Center., Memphis, USA )
22 Nov 2019
The cancer groundshot: Going global before going to the moon
Dr Bishal Gyawali - Queen's University, Kingston, Canada
The cancer groundshot: Going global before going to the moon ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Nov 2019